Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple

L A Haglund1, G R Istre, D A Pickett

  • 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.

Insights

Antibiotic resistance in invasive pneumococcal disease is a growing concern. This study in Oklahoma found significant rates of penicillin and other antibiotic resistance in pneumococcal infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Invasive pneumococcal disease (IPD) remains a significant public health concern.
  • Understanding antibiotic resistance patterns is crucial for effective treatment and prevention strategies.
  • Previous data from central Oklahoma indicated low levels of high-level antibiotic resistance in pneumococci.

Purpose of the Study:

  • To evaluate the antibiotic susceptibility and serotype distribution of invasive pneumococcal disease (IPD) in the Oklahoma City metropolitan area.
  • To determine the prevalence of antibiotic resistance in *Streptococcus pneumoniae* isolates causing IPD.
  • To assess IPD rates in different demographic groups, including the elderly and nursing home residents.

Main Methods:

  • A prospective study collected 144 cases of IPD over one year in the Oklahoma City metropolitan area.
  • Antibiotic susceptibility testing was performed on *Streptococcus pneumoniae* isolates.
  • Demographic data, including age and residency (nursing home vs. non-resident), were collected to calculate disease rates.

Main Results:

  • The overall incidence of IPD was 16.9 cases per 100,000 population.
  • Antibiotic-resistant organisms accounted for 19.4% of IPD cases.
  • Relative penicillin resistance was observed in 7.6% of isolates, with high-level penicillin resistance in 1.4%. Resistance to erythromycin and/or trimethoprim-sulfamethoxazole was 11%, with 5% exhibiting dual resistance.
  • IPD rates were substantially higher in nursing home residents (352/100,000) compared to non-residents (25.6/100,000) in the elderly population (≥60 years).

Conclusions:

  • Antibiotic resistance, particularly relative penicillin resistance, is present in invasive pneumococcal disease in Oklahoma City.
  • The findings highlight the need for ongoing surveillance of antibiotic resistance patterns in *Streptococcus pneumoniae*.
  • Targeted prevention and treatment strategies may be necessary for high-risk populations like elderly nursing home residents.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...